Developing New Medicines Through Artificial Intelligence
On September 30, 2012, a computer program named “AlexNet” won an international competition and ushered in a new age of artificial intelligence (AI)....
BLOG
Read on
How Resilience Is Bringing Forward Thinking to Disrupt the Biomanufacturing Landscape to Increase Access to Medicines
While many biopharmaceutical companies are built to fulfil a need, Resilience was built to serve innovation. Founded during the COVID-19 pandemic in...
Overcoming Obstacles in Gene Therapy Manufacturing
The gene therapy and viral vector space has yet to achieve the level of standardization that typifies established modalities, such as monoclonal...
Resilience Enters Into Strategic Collaboration with Labcorp to Accelerate Cell and Gene Therapies
Resilience has entered into a strategic collaboration with Labcorp to establish a joint customer service offering that provides an end-to-end...
Problem Solving for Aseptic Filling
How the thoughtful adoption of new technology can both problem-solve and future- proof critical processes in biomanufacturing For any forward-facing...
On Demand Webinar: Outsourced Pharma Capacity Update-Large Molecules
Are you an innovator company looking for a reliable and innovative partner? You have come to the right place.
Leveraging Partnerships to Achieve Cell Therapy Success
What impact can partnerships have in cell therapy commercialization success? Eytan Abraham at Resilience discusses the need for a modernized...
Master Cell Banks: Laying the Foundation to Final Product Success
Consider our top 5 FAQs when it comes to MCBs Master cell banks (MCBs) are a critical starting material that lay the foundation for the scale-up and...
